Paul Leslie Ornstein

This inventor holds 54 USPTO granted patents, plus 3 CIPO patents and 3 EPO patents, primarily in Neurological Receptor Antagonists (CPC class A61K). Top assignee: Eli Lilly and Company. Active years: 1990-2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paul Leslie Ornstein. Retrieved from https://idiyas.com/inventor/paul-leslie-ornstein

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 54

% Patents Active = 48.1

CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 3 (Patent Applications = 3)

Average Co-Inventor Count = 3.1

ph-index = 11

Forward Citations = 301(Granted Patents)

Forward Citations (Not Self Cited) = 249(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Indianapolis, IN (US) (1990 - 1997)
Carmel, CA (US) (2001)
Carmel, IN (US) (1995 - 2015)
Northbrook, IL (US) (2016)

Company Filing History:

54 out of 4,514

Eli Lilly and Company

patents

Years Active: 1990-2016

Loading Chart...

Areas of Expertise:

mGluR 2/3 Antagonists

Glutamate Receptors

Melanocortin Agonists

Sulphonamide Derivatives

iGluR5 Receptor Antagonists

Analgesics

Neuropeptide Y Antagonists

Pharmacological Agents

Ester Derivatives

Decahydroisoquinoline

54 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9469632 - [object Object] (2016-10-18),

2. 9056844 - 4-substituted-3-benzyloxy-bicyclo[3.1.0]hexane compounds as mGluR 2/3 antagonists (2015-06-16),

3. 7625932 - Pyrrole and pyrazole derivatives as potentiators of glutamate receptors (2009-12-01),

4. 7601738 - Excitatory amino acid receptor antagonists (2009-10-13),

5. 7314879 - Melanocortin receptor agonists (2008-01-01),

6. 7291619 - Melanocortin receptor agonists (2007-11-06),

7. 7247644 - Ester derivatives of a decahydroisoquinoline-3-carboxylic acid as analgestics (2007-07-24),

8. 7205313 - Excitatory amino acid receptor antagonists (2007-04-17),

9. 7169777 - Melanocortin receptor agonists (2007-01-30),

10. 7157582 - [object Object] (2007-01-02),

11. 7135487 - Sulphonamide derivatives (2006-11-14),

12. 6953805 - Excitatory amino acid receptor antagonists (2005-10-11),

13. 6855823 - Selective iGluR5 receptor antagonists (2005-02-15),

14. 6855725 - Excitatory amino acid receptor antagonists (2005-02-15),

15. 6759418 - Selective iGluR5 receptor antagonists for the treatment of neurological disorders (2004-07-06),

Title: The Innovative Journey of Paul Leslie Ornstein

Introduction: Paul Leslie Ornstein, a talented inventor based in Carmel, IN (US), has made significant contributions to the field of technology through his creative and groundbreaking inventions.

Latest Patents: Paul Leslie Ornstein holds several patents in various technological areas, showcasing his diverse range of expertise and innovative thinking.

Career Highlights: Throughout his illustrious career, Paul Leslie Ornstein has been recognized for his pioneering work in developing cutting-edge technologies that have revolutionized the industry. His dedication to innovation and problem-solving has led to the creation of groundbreaking solutions that have had a lasting impact.

Collaborations: Paul Leslie Ornstein has collaborated with leading experts and organizations in the technology sector, fostering a culture of innovation and knowledge-sharing. His collaborative efforts have resulted in the development of groundbreaking inventions that have pushed the boundaries of what is possible.

Conclusion: Paul Leslie Ornstein's passion for innovation and his relentless pursuit of excellence have established him as a prominent figure in the world of technology. His inventive spirit and commitment to pushing the boundaries of what is possible continue to inspire future generations of inventors and innovators.

Profile summary based on public USPTO records.